• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

NESCO Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
505355
INE317F01035
425.2758577
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NESCO
18.55
7742.85
EPS(TTM)
Face Value()
Div & Yield %
59.24
2
0.64
 

modern engineering & projects limited
Eiko Lifesciences consolidated net profit rises 23.81% in the March 2026 quarter
May 26,2026
Net profit of Eiko Lifesciences rose 23.81% to Rs 1.30 crore in the quarter ended March 2026 as against Rs 1.05 crore during the previous quarter ended March 2025. Sales rose 62.73% to Rs 18.34 crore in the quarter ended March 2026 as against Rs 11.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 113.27% to Rs 4.50 crore in the year ended March 2026 as against Rs 2.11 crore during the previous year ended March 2025. Sales rose 39.96% to Rs 52.71 crore in the year ended March 2026 as against Rs 37.66 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales18.3411.27 63 52.7137.66 40
OPM %12.3211.62 -14.107.33 -
PBDT2.271.55 46 8.133.46 135
PBT2.021.30 55 7.122.72 162
NP1.301.05 24 4.502.11 113